Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology ...
Forget the so-called 'Pulsed-Field Ablation Wars'—competition in the continuous glucose monitor (CGM) market is just as fierce. There have been several key approvals in the space, and on Monday, ...
GALWAY, Ireland, Dec. 2, 2025 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Simplera CGM features a one-hand, two-step insertion ...
Medtronic’s (NYSE:MDT) Simplera continuous glucose monitor (CGM) has received regulatory approval from the U.S. Food and Drug Administration (FDA). Simplera is the company's first disposable, ...
Unique partnership with Medtronic will enable continuous glucose monitoring (CGM) sensors based on Abbott's FreeStyle Libre sensing technology to integrate with Medtronic's insulin delivery systems ...
Real-time actionable insights on one mobile app for people who manage their diabetes using multiple daily injections GALWAY, Ireland, Feb. 25, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global ...
Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...
DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results